Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.
J Clin Oncol
; 42(8): 915-926, 2024 Mar 10.
Article
en En
| MEDLINE
| ID: mdl-38096462
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Asparaginasa
/
Leucemia-Linfoma Linfoblástico de Células Precursoras
Idioma:
En
Revista:
J Clin Oncol
Año:
2024
Tipo del documento:
Article